Innovotech Inc.
TSX VENTURE : IOT

Innovotech Inc.

August 15, 2006 10:56 ET

Innovotech Biofilm Sensitivity Diagnostic Kit Receives Canadian Regulatory Approval

EDMONTON, ALBERTA--(CCNMatthews - Aug. 15, 2006) - Innovotech (TSX VENTURE:IOT) is pleased to announce that Health Canada has approved its bioFILM PA antimicrobial sensitivity kit for sale in Canada. The company also announces that PML Microbiologicals, a leading manufacturer of culture media and microbiological products throughout North America has been selected as manufacturer of the device.

"The bioFILM PA kit is a world break-through in the treatment of chronic infectious diseases. It allows physicians to assess the effectiveness of combinations of antibiotics against a specific patient's biofilm infection." states Dr. Wolfgang Muhs, CEO of Innovotech. "Biofilm infections like cystic fibrosis lung disease and ventilator-acquired pneumonia are very difficult to treat. In the past, physicians were required to make an educated guess, often based on an MIC (minimum inhibitory concentration) test, which is inappropriate in a biofilm infection."

The bioFILM PA kit is the first of many kits that the company will develop each focusing on a specific species of microorganism. The Center for Disease Control and Prevention states that over 60% of all human infections and virtually all chronic infections are caused by biofilm organisms. The company believes that these products will benefit both patients, through improvements in quality of life and also health systems, through more cost efficient treatment of disease and reduced chance of bacterial resistance.

About Innovotech Inc.

The company's expertise is microbial biofilms, a documented state of microorganisms. The company uses its patented technology, the MBEC Assay, to develop antimicrobial products and diagnostic tests to treat biofilm infestations, and to provide specialized services to clients in human health, agriculture and industry.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Innovotech Inc.
    Dr. Wolfgang Muhs
    CEO
    (780) 448-0585
    (780) 424-0941 (FAX)
    or
    Innovotech Inc.
    Ken Boutilier
    President
    (780) 425-7717
    (780) 424-0941 (FAX)
    Website: www.mbec.ca